Heart and Lung Transplants from HCV-Infected Donors
To the Editor: Woolley et al. (April 25 issue) 1 report encouraging results of the Donors of Hepatitis C NAT [nucleic acid amplification test] Positive Thoracic Allografts for Transplantation Evaluation in Non-HCV Recipients (DONATE HCV) trial, which showed safety and efficacy of preemptive direct-a...
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 2019-09, Vol.381 (10), p.987-989 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 989 |
|---|---|
| container_issue | 10 |
| container_start_page | 987 |
| container_title | The New England journal of medicine |
| container_volume | 381 |
| creator | Elfeki, Mohamed A Romero-Marrero, Carlos Carey, William D Indolfi, Giuseppe Azzari, Chiara Resti, Massimo Nitta, Daisuke Imamura, Teruhiko Woolley, Ann E Fanikos, John Baden, Lindsey R |
| description | To the Editor:
Woolley et al. (April 25 issue)
1
report encouraging results of the Donors of Hepatitis C NAT [nucleic acid amplification test] Positive Thoracic Allografts for Transplantation Evaluation in Non-HCV Recipients (DONATE HCV) trial, which showed safety and efficacy of preemptive direct-acting antiviral therapy immediately after transplantation to treat hepatitis C virus (HCV)–negative lung-transplant and heart-transplant recipients who received grafts from donors with hepatitis C viremia. In the accompanying editorial,
2
there was concern regarding assurance of access to direct-acting antiviral therapy in advance of acceptance of a heart or lung from donors with hepatitis C viremia. Patients with Medicare . . . |
| doi_str_mv | 10.1056/NEJMc1907009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2285104001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2284703474</sourcerecordid><originalsourceid>FETCH-LOGICAL-c554t-102857280a09587f25d14bdaebc6338441f098dd6ccfd9f3a3ca0bcaa2d3dcc73</originalsourceid><addsrcrecordid>eNqN0T1PwzAQBmALgWgpbMwoEgwMBM6xHccjKoUWFVgKa-T4A7VqnGInA_8eVy0IIYbe4uXR6zu9CJ1iuMbA8pvn0eOTwgI4gNhDfcwISSmFfB_1AbIipVyQHjoKYQFxMBWHqEcwLYjgrI_I2EjfJtLpZNq592TmpQurpXRtSKxv6mQ8fEsnzhrVGp3cNa7x4RgdWLkM5mT7DtDr_Wg2HKfTl4fJ8HaaKsZom-L4O-NZARIEK7jNmMa00tJUKiekoBRbEIXWuVJWC0skURIqJWWmiVaKkwG63OSufPPRmdCW9Twos4zbmaYLZRbzMdB41I40YyTflRJY0_M_dNF03sWb14pyIJTTqK42SvkmBG9sufLzWvrPEkO5rqj8XVHkZ9vQrqqN_sHfnURwsQF1HUpnFvX_OV-xa5L4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2284703474</pqid></control><display><type>article</type><title>Heart and Lung Transplants from HCV-Infected Donors</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Elfeki, Mohamed A ; Romero-Marrero, Carlos ; Carey, William D ; Indolfi, Giuseppe ; Azzari, Chiara ; Resti, Massimo ; Nitta, Daisuke ; Imamura, Teruhiko ; Woolley, Ann E ; Fanikos, John ; Baden, Lindsey R</creator><creatorcontrib>Elfeki, Mohamed A ; Romero-Marrero, Carlos ; Carey, William D ; Indolfi, Giuseppe ; Azzari, Chiara ; Resti, Massimo ; Nitta, Daisuke ; Imamura, Teruhiko ; Woolley, Ann E ; Fanikos, John ; Baden, Lindsey R</creatorcontrib><description>To the Editor:
Woolley et al. (April 25 issue)
1
report encouraging results of the Donors of Hepatitis C NAT [nucleic acid amplification test] Positive Thoracic Allografts for Transplantation Evaluation in Non-HCV Recipients (DONATE HCV) trial, which showed safety and efficacy of preemptive direct-acting antiviral therapy immediately after transplantation to treat hepatitis C virus (HCV)–negative lung-transplant and heart-transplant recipients who received grafts from donors with hepatitis C viremia. In the accompanying editorial,
2
there was concern regarding assurance of access to direct-acting antiviral therapy in advance of acceptance of a heart or lung from donors with hepatitis C viremia. Patients with Medicare . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMc1907009</identifier><identifier>PMID: 31483975</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Allografts ; Antiviral agents ; Donors ; Heart transplantation ; Hepatitis ; Hepatitis C ; Humans ; Interferon ; Lung Transplantation ; Thorax ; Tissue Donors ; Transplants & implants ; Viremia</subject><ispartof>The New England journal of medicine, 2019-09, Vol.381 (10), p.987-989</ispartof><rights>Copyright © 2019 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c554t-102857280a09587f25d14bdaebc6338441f098dd6ccfd9f3a3ca0bcaa2d3dcc73</citedby><cites>FETCH-LOGICAL-c554t-102857280a09587f25d14bdaebc6338441f098dd6ccfd9f3a3ca0bcaa2d3dcc73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMc1907009$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2284703474?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,2759,2760,26103,27924,27925,52382,54064,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31483975$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elfeki, Mohamed A</creatorcontrib><creatorcontrib>Romero-Marrero, Carlos</creatorcontrib><creatorcontrib>Carey, William D</creatorcontrib><creatorcontrib>Indolfi, Giuseppe</creatorcontrib><creatorcontrib>Azzari, Chiara</creatorcontrib><creatorcontrib>Resti, Massimo</creatorcontrib><creatorcontrib>Nitta, Daisuke</creatorcontrib><creatorcontrib>Imamura, Teruhiko</creatorcontrib><creatorcontrib>Woolley, Ann E</creatorcontrib><creatorcontrib>Fanikos, John</creatorcontrib><creatorcontrib>Baden, Lindsey R</creatorcontrib><title>Heart and Lung Transplants from HCV-Infected Donors</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>To the Editor:
Woolley et al. (April 25 issue)
1
report encouraging results of the Donors of Hepatitis C NAT [nucleic acid amplification test] Positive Thoracic Allografts for Transplantation Evaluation in Non-HCV Recipients (DONATE HCV) trial, which showed safety and efficacy of preemptive direct-acting antiviral therapy immediately after transplantation to treat hepatitis C virus (HCV)–negative lung-transplant and heart-transplant recipients who received grafts from donors with hepatitis C viremia. In the accompanying editorial,
2
there was concern regarding assurance of access to direct-acting antiviral therapy in advance of acceptance of a heart or lung from donors with hepatitis C viremia. Patients with Medicare . . .</description><subject>Allografts</subject><subject>Antiviral agents</subject><subject>Donors</subject><subject>Heart transplantation</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>Humans</subject><subject>Interferon</subject><subject>Lung Transplantation</subject><subject>Thorax</subject><subject>Tissue Donors</subject><subject>Transplants & implants</subject><subject>Viremia</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqN0T1PwzAQBmALgWgpbMwoEgwMBM6xHccjKoUWFVgKa-T4A7VqnGInA_8eVy0IIYbe4uXR6zu9CJ1iuMbA8pvn0eOTwgI4gNhDfcwISSmFfB_1AbIipVyQHjoKYQFxMBWHqEcwLYjgrI_I2EjfJtLpZNq592TmpQurpXRtSKxv6mQ8fEsnzhrVGp3cNa7x4RgdWLkM5mT7DtDr_Wg2HKfTl4fJ8HaaKsZom-L4O-NZARIEK7jNmMa00tJUKiekoBRbEIXWuVJWC0skURIqJWWmiVaKkwG63OSufPPRmdCW9Twos4zbmaYLZRbzMdB41I40YyTflRJY0_M_dNF03sWb14pyIJTTqK42SvkmBG9sufLzWvrPEkO5rqj8XVHkZ9vQrqqN_sHfnURwsQF1HUpnFvX_OV-xa5L4</recordid><startdate>20190905</startdate><enddate>20190905</enddate><creator>Elfeki, Mohamed A</creator><creator>Romero-Marrero, Carlos</creator><creator>Carey, William D</creator><creator>Indolfi, Giuseppe</creator><creator>Azzari, Chiara</creator><creator>Resti, Massimo</creator><creator>Nitta, Daisuke</creator><creator>Imamura, Teruhiko</creator><creator>Woolley, Ann E</creator><creator>Fanikos, John</creator><creator>Baden, Lindsey R</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20190905</creationdate><title>Heart and Lung Transplants from HCV-Infected Donors</title><author>Elfeki, Mohamed A ; Romero-Marrero, Carlos ; Carey, William D ; Indolfi, Giuseppe ; Azzari, Chiara ; Resti, Massimo ; Nitta, Daisuke ; Imamura, Teruhiko ; Woolley, Ann E ; Fanikos, John ; Baden, Lindsey R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c554t-102857280a09587f25d14bdaebc6338441f098dd6ccfd9f3a3ca0bcaa2d3dcc73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Allografts</topic><topic>Antiviral agents</topic><topic>Donors</topic><topic>Heart transplantation</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>Humans</topic><topic>Interferon</topic><topic>Lung Transplantation</topic><topic>Thorax</topic><topic>Tissue Donors</topic><topic>Transplants & implants</topic><topic>Viremia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elfeki, Mohamed A</creatorcontrib><creatorcontrib>Romero-Marrero, Carlos</creatorcontrib><creatorcontrib>Carey, William D</creatorcontrib><creatorcontrib>Indolfi, Giuseppe</creatorcontrib><creatorcontrib>Azzari, Chiara</creatorcontrib><creatorcontrib>Resti, Massimo</creatorcontrib><creatorcontrib>Nitta, Daisuke</creatorcontrib><creatorcontrib>Imamura, Teruhiko</creatorcontrib><creatorcontrib>Woolley, Ann E</creatorcontrib><creatorcontrib>Fanikos, John</creatorcontrib><creatorcontrib>Baden, Lindsey R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elfeki, Mohamed A</au><au>Romero-Marrero, Carlos</au><au>Carey, William D</au><au>Indolfi, Giuseppe</au><au>Azzari, Chiara</au><au>Resti, Massimo</au><au>Nitta, Daisuke</au><au>Imamura, Teruhiko</au><au>Woolley, Ann E</au><au>Fanikos, John</au><au>Baden, Lindsey R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heart and Lung Transplants from HCV-Infected Donors</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2019-09-05</date><risdate>2019</risdate><volume>381</volume><issue>10</issue><spage>987</spage><epage>989</epage><pages>987-989</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>To the Editor:
Woolley et al. (April 25 issue)
1
report encouraging results of the Donors of Hepatitis C NAT [nucleic acid amplification test] Positive Thoracic Allografts for Transplantation Evaluation in Non-HCV Recipients (DONATE HCV) trial, which showed safety and efficacy of preemptive direct-acting antiviral therapy immediately after transplantation to treat hepatitis C virus (HCV)–negative lung-transplant and heart-transplant recipients who received grafts from donors with hepatitis C viremia. In the accompanying editorial,
2
there was concern regarding assurance of access to direct-acting antiviral therapy in advance of acceptance of a heart or lung from donors with hepatitis C viremia. Patients with Medicare . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>31483975</pmid><doi>10.1056/NEJMc1907009</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 2019-09, Vol.381 (10), p.987-989 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2285104001 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; New England Journal of Medicine |
| subjects | Allografts Antiviral agents Donors Heart transplantation Hepatitis Hepatitis C Humans Interferon Lung Transplantation Thorax Tissue Donors Transplants & implants Viremia |
| title | Heart and Lung Transplants from HCV-Infected Donors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T08%3A28%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heart%20and%20Lung%20Transplants%20from%20HCV-Infected%20Donors&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Elfeki,%20Mohamed%20A&rft.date=2019-09-05&rft.volume=381&rft.issue=10&rft.spage=987&rft.epage=989&rft.pages=987-989&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMc1907009&rft_dat=%3Cproquest_cross%3E2284703474%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2284703474&rft_id=info:pmid/31483975&rfr_iscdi=true |